No abstract available
MeSH terms
-
Anti-HIV Agents / adverse effects*
-
Anti-HIV Agents / therapeutic use
-
Atazanavir Sulfate
-
Female
-
HIV Infections / drug therapy*
-
Humans
-
Hyperbilirubinemia / chemically induced*
-
Hyperbilirubinemia / epidemiology*
-
Infant, Newborn
-
Oligopeptides / adverse effects*
-
Oligopeptides / therapeutic use
-
Pregnancy
-
Pregnancy Complications, Infectious / drug therapy
-
Pregnant Women
-
Prevalence
-
Pyridines / adverse effects*
-
Pyridines / therapeutic use
-
Risk Assessment
Substances
-
Anti-HIV Agents
-
Oligopeptides
-
Pyridines
-
Atazanavir Sulfate